News

Case Study: IViG Keeps Alzheimer's at Bay for a Decade
By STACEY SCHOTT, M.D., and SUSAN DONALDSON JAMES
July 19, 2012—abcnews.go.com

Small Trial Shows New Drug Keeps Memory, Mood and Function Stable

Jason Marder watched...

By Alex Crees

Published July 19, 2012 | FoxNews.com

High levels of a certain type of fat in the blood may increase a person's risk of Alzheimer's disease, according to a new study.

As part of the Women's Health and Aging...

ACCREA PRESS RELEASE (http://accerapharma.com/2009/news42.html)

Tips for Caregivers and a New Therapy Offers Hope in the Fight Against Alzheimer's...

A compound that previously progressed to Phase II clinical trials for cancer treatment slows neurological damage and improves brain function in an animal model of Alzheimer's disease, according to a study in the March 14 issue of The Journal of...

A study published this week in the Journal of Neuroscience shows that the compound epothilone D (EpoD) is effective in preventing further neurological damage and improving cognitive performance in a mouse model of Alzheimer's disease (AD). The...

For every individual who's a victim of Alzheimer's - some 5.4 million persons in the United States alone - there's a related victim: the caregiver. Spouse, son, daughter, other relative or friend, the loneliness, exhaustion, fear and most of all...

A team of academic researchers has identified the intracellular mechanisms regulated by vitamin D3 that may help the body clear the brain of amyloid beta, the main component of plaques associated with Alzheimer's disease.

Published in the...

Researchers at the University of California, San Diego, the Medical University of South Carolina, the University of Cincinnati, and American Life Science Pharmaceuticals of San Diego have validated the protease cathepsin B (CatB) as a target for...

Pages